chr10-93681512-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate

The NM_145246.5(FRA10AC1):​c.755C>T​(p.Ser252Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000007 in 1,427,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

FRA10AC1
NM_145246.5 missense

Scores

7
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.94

Publications

0 publications found
Variant links:
Genes affected
FRA10AC1 (HGNC:1162): (FRA10A associated CGG repeat 1) The protein encoded by this gene is a nuclear phosphoprotein of unknown function. This gene contains a tandem CGG repeat region within a CpG island that normally consists of 8-14 repeats but can expand to over 200 repeats. The repeat region is within the 5' UTR of some transcript variants, but is intronic to another variant. The expanded repeat allele is a fragile site and becomes hypermethylated, causing a reduction in gene expression. A disease phenotype has not been associated with expanded alleles. This gene is found within the rare FRA10A folate-sensitive fragile site. [provided by RefSeq, Dec 2016]
FRA10AC1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity F10C1_HUMAN
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11266157).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FRA10AC1NM_145246.5 linkc.755C>T p.Ser252Phe missense_variant Exon 11 of 14 ENST00000359204.5 NP_660289.2 Q70Z53-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FRA10AC1ENST00000359204.5 linkc.755C>T p.Ser252Phe missense_variant Exon 11 of 14 1 NM_145246.5 ENSP00000360488.3 Q70Z53-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000898
AC:
2
AN:
222762
AF XY:
0.0000165
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000128
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.00e-7
AC:
1
AN:
1427798
Hom.:
0
Cov.:
27
AF XY:
0.00000141
AC XY:
1
AN XY:
710276
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30832
American (AMR)
AF:
0.00
AC:
0
AN:
36682
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25448
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38332
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79450
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52448
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5652
European-Non Finnish (NFE)
AF:
9.09e-7
AC:
1
AN:
1100000
Other (OTH)
AF:
0.00
AC:
0
AN:
58954
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
May 20, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.755C>T (p.S252F) alteration is located in exon 11 (coding exon 10) of the FRA10AC1 gene. This alteration results from a C to T substitution at nucleotide position 755, causing the serine (S) at amino acid position 252 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.44
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.032
T
Eigen
Benign
0.15
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.76
T
M_CAP
Benign
0.0090
T
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
2.9
PrimateAI
Benign
0.38
T
PROVEAN
Uncertain
-2.9
D
REVEL
Benign
0.040
Sift
Uncertain
0.014
D
Sift4G
Uncertain
0.023
D
Polyphen
0.38
B
Vest4
0.21
MutPred
0.27
Loss of phosphorylation at S252 (P = 2e-04);
MVP
0.46
MPC
0.081
ClinPred
0.76
D
GERP RS
5.2
Varity_R
0.11
gMVP
0.23
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs777753842; hg19: chr10-95441269; API